Replies to post #11220 on Opko Health Inc (OPK)

[Juice555]

Seems like we totally forgot about all the pipeline items we got going on

The COVID 19 testing giving us a boost and attention hope Dr. Frost will know how to increase shareholder value

[Femto99]

8) In Spain, based on a pilot study carried out at the Reina Sofia University Hospital (Córdoba) in 76 hospitalized patients demonstrating a reduced ICU admission by more than 50 % among patients assigned to calcifediol treatment, a trial of calcifediol supplementation started on April 29th 2020. The trial is registered as “Prevention and treatment with Calcifediol of Coronavirus induced acute respiratory syndrome (SARS) COVID-19 (COVIDIOL)” (NCT04366908). It is a multi-center, randomized, open-label clinical trial to study the efficacy and safety of calcifediol in hospitalized patients with confirmed SARS-CoV-2 infection causing respiratory disease undergoing treatment with the best available therapy administering Calcifediol or not (calcifediol in soft capsules: 0.532 mg on the day of admission and 0.266 mg on day 3 and 7 and then weekly until discharge or ICU admission). Admission to Intensive Care Unit or death are the primary outcomes.